DIVERSIFIED HEALTHCARE TRUST
At today's price, DIVERSIFIED HEALTHCARE TRUST (DHC) is priced for today's economics sustained for ~5.5 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• Diversified Healthcare Trust is a turnaround in motion: a healthcare real estate trust whose senior-housing operating portfolio is recovering, with same-property net operating income up 13.5% and management guiding a 300 basis point occupancy gain for 2026 [Source: Q1 2026 results, May 2026]. • The biggest risk is the balance sheet, still heavily levered at net debt near eight times EBITDA, even after asset sales cut interest expense sharply and earned a Moody's upgrade to B3 from Caa1 [Source
Is DHC overvalued? See what's priced in →
222 institutional managers reported holding DHC in 13F filings for the quarter ended 2026-03-31. Together they hold about 82% of the company; the top 10 hold 55%. 39 opened new positions that quarter. Held by BlackRock, Vanguard Group, State Street, among others. On the short side, 10.2M shares were sold short as of the 2026-06-15 count, about 4% of shares outstanding (4.9 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
DHC's share count grew 1.2% over the past five years even with $3.02M spent on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting); the current rate is $0.04 a share annually. Cash returned over the past three years: $26.51M in dividends and $2.50M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at DHC over the trailing three years: 2024: 1 buy totaling $5k; 2025: 1 buy totaling $98k. 8 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
DHC's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-02 | +12.5% | -19.2% |
| 2023-11-02 | +7.3% | +50.9% |
| 2024-02-27 | +8.4% | -26.3% |
| 2024-05-07 | -11.4% | +36.0% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
DHC's latest 8-K filings: 2026-06-12 (items 5.07, 9.01); 2026-06-01 (items 7.01, 9.01); 2026-05-05 (items 7.01, 9.01); 2026-05-04 (items 2.02, 9.01); 2026-02-24 (items 7.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.